Clinical studies recruiting near Norfolk

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · DaVita Clinical Research Norfolk · R1 Therapeutics · NCT06712654 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · USO - Virginia Oncology Associates · Eli Lilly and Company · NCT07218380 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10009, Norfolk, VA · Colorado Prevention Center · NCT06024746 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0188 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Virginia Oncology Associates (VOA) ( Site 8008) · Merck Sharp & Dohme LLC · NCT06393374 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Children's Hospital of The King's Daughters · National Cancer Institute (NCI) · NCT05099003 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma R&D · NCT06988605 A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Phase 3 · Virginia Oncology Associates · BioNTech SE · NCT07365995 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · AMR Clinical - Norfolk · Kallyope Inc. · NCT07674654 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Children's Specialty Group - 3 Commercial Place · H. Lundbeck A/S · NCT05897320 Two Dose Levels of Privigen in Pediatric CIDP
Phase 4 · Children's Specialty Group · CSL Behring · NCT03684018 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Sanofi · NCT07190196 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Virginia Oncology Associates · Hoffmann-La Roche · NCT06793215 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Children's Hospital of The King's Daughters · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Children's Hospital of The King's Daughters · National Cancer Institute (NCI) · NCT05691478 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Virginia Oncology Associates · Pfizer · NCT07421700 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Eximia Research-VA, LLC · Eli Lilly and Company · NCT07415044 Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Olympus Corporation of the Americas · NCT04757116 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Janssen Research & Development, LLC · NCT07499232 Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · Cambridge University Hospitals NHS Foundation Trust · NCT05093231 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · University College, London · NCT05604963 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · James Paget University Hospitals NHS Foundation Trust · Hoffmann-La Roche · NCT07284121 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Virginia Oncology Associates · Amgen · NCT04221542 Non-Invasive Preeclampsia Screening and Biobank
Phase N/A · Macon & Joan Brock Virginia Health Sciences at Old Dominion · Sequenom, Inc. · NCT06643741 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Hospital of The King's Daughters · Children's Oncology Group · NCT04322318 Food Orders on Blood Glucose and Fuel Use At Rest
NA · Old Dominion University Human Performance Laboratory · Old Dominion University · NCT06763562 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0408 · Celgene · NCT05519085 Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stag
Phase 2 · Virginia Oncology Associates (VOA) ( Site 8001) · Merck Sharp & Dohme LLC · NCT06797635 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Norfolk and Norwich University Hospital · Boehringer Ingelheim · NCT06531824

Look up another city

Look up another condition